Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies

References

• Beraldo H, Gambino D. The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. Mini Rev Med Chem 2004;4:31–39.
   PubMed Web of Science ®Google Scholar
• Asghar SF, Yasin KA, Aziz S. Synthesis and cyclisation of 1,4-disubstituted semicarbazides. Nat Prod Res 2010;24:315–325.
   PubMed Web of Science ®Google Scholar
• Zhang R, Durkin JP, Windsor WT. Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease. Bioorg Med Chem Lett 2002;12:1005–1008.
   PubMedGoogle Scholar
• Bailey MD, Halmos T, Goudreau N, Lescop E, Llinàs-Brunet M. Novel azapeptide inhibitors of hepatitis C virus serine protease. J Med Chem 2004;47:3788–3799.
   PubMed Web of Science ®Google Scholar
• Ferrari MB, Capacchi S, Reffo G, Pelosi G, Tarasconi P, Albertini R et al. Synthesis, structural characterization and biological activity of p-fluorobenzaldehyde thiosemicarbazones and of a nickel complex. J Inorg Biochem 2000;81:89–97.
   PubMed Web of Science ®Google Scholar
• Klayman DL, Lin AJ, Hoch JM, Scovill JP, Lambros C, Dobek AS. 2-Acetylpyridine thiosemicarbazones XI: 2-(alpha-Hydroxyacetyl)pyridine thiosemicarbazones as antimalarial and antibacterial agents. J Pharm Sci 1984;73:1763–1767.
   PubMedGoogle Scholar
• Ren S, Wang R, Komatsu K, Bonaz-Krause P, Zyrianov Y, McKenna CE et al. Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. J Med Chem 2002;45:410–419.
   PubMed Web of Science ®Google Scholar
• Shao J, Zhou B, Zhu L, Bilio AJ, Su L, Yuan YC et al. Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Biochem Pharmacol 2005;69:627–634.
   PubMedGoogle Scholar
• Finch RA, Liu M, Grill SP, Rose WC, Loomis R, Vasquez KM et al. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem Pharmacol 2000;59:983–991.
   PubMed Web of Science ®Google Scholar
• Kolesar J, Brundage RC, Pomplun M, Alberti D, Holen K, Traynor A et al. Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients. Cancer Chemother Pharmacol 2011;67:393–400.
   PubMedGoogle Scholar
• Bondebjerg J, Fuglsang H, Valeur KR, Kaznelson DW, Hansen JA, Pedersen RO et al. Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI). Bioorg Med Chem 2005;13:4408–4424.
   PubMed Web of Science ®Google Scholar
• Lemke TL, Williams DA, Roche VF, Zito SW. Foye’s Principles of Medicinal Chemistry, 6th Ed.,Philadelphia: Lippincott Williams & Wilkins, 2008.
   Google Scholar
• Holland KP, Elford HL, Bracchi V, Annis CG, Schuster SM, Chakrabarti D. Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives. Antimicrob Agents Chemother 1998;42:2456–2458.
   PubMed Web of Science ®Google Scholar
• Klayman DL, Acton N, Scovill JP. 2-Acetylpyridine thiosemicarbazones. 12. Derivatives of 3-acetylisoquinoline as potential antimalarial agents. Arzneimittelforschung 1986;36:10–13.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Yeh S, Nell M, van Rensburg CE, Chibale K. Synthesis of new 7-chloroquinolinyl thioureas and their biological investigation as potential antimalarial and anticancer agents. Bioorg Med Chem Lett 2007;17:5683–5685.
   PubMed Web of Science ®Google Scholar
• Fernandes I, Vale N, de Freitas V, Moreira R, Mateus N, Gomes P. Anti-tumoral activity of imidazoquines, a new class of antimalarials derived from primaquine. Bioorg Med Chem Lett 2009;19:6914–6917.
   PubMedGoogle Scholar
• Jones M, Mercer AE, Stocks PA, La Pensée LJ, Cosstick R, Park BK et al. Antitumour and antimalarial activity of artemisinin-acridine hybrids. Bioorg Med Chem Lett 2009;19:2033–2037.
   PubMed Web of Science ®Google Scholar
• Rosenthal AS, Chen X, Liu JO, West DC, Hergenrother PJ, Shapiro TA et al. Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. J Med Chem 2009;52:1198–1203.
   PubMed Web of Science ®Google Scholar
• Dzimbeg G, Zorc B, Kralj M, Ester K, Pavelic K, Andrei G et al. The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations. Eur J Med Chem 2008;43:1180–1187.
   PubMed Web of Science ®Google Scholar
• Simunovic M, Perkovic I, Zorc B, Ester K, Kralj M, Hadjipavlou-Litina D et al. Urea and carbamate derivatives of primaquine: synthesis, cytostatic and antioxidant activities. Bioorg Med Chem 2009;17:5605–5613.
   PubMed Web of Science ®Google Scholar
• Rajic Z, Koncic MZ, Miloloža K, Perkovic I, Butula I, Bucar F et al. Primaquine-NSAID twin drugs: Synthesis, radical scavenging, antioxidant and Fe2+ chelating activity. Acta Pharm 2010;60:325–337.
   PubMedGoogle Scholar
• Perković I, Butula I, Kralj M, Martin-Kleiner I, Balzarini J, Hadjipavlou-Litina D, Katsori A-M, Zorc B. Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy)carbamoylcarbazides as potential anticancer agents and antioxidants. Eur J Med Chem (In press).
   Google Scholar
• Butula I, Proštenik M, Vela V. Reactions with 1-benzotriazole carboxylic acid chloride. I. Synthesis of the 2,6-bis(hydroxymethyl)pyridine dicarbamates. Croat Chem Acta 1977;49:837–42.
   Google Scholar
• Kalčić I, Zovko M, Jadrijević-Mladar Takač M, Zorc B, Butula I. Synthesis and reactions of some azolecarboxylic acid derivatives. Croat Chem Acta 2003;76:217–28.
   Google Scholar
• Butula I, Vela V, Ivezić B. Reaktionen mit 1-Benzotriazol carbonsaurechlorid.IV.Synthese von substituierten Harnstoffen, Semicarbaziden und Carbaziden. Croat Chem Acta 1978;51:339–46.
   Google Scholar
• Rajic Z, Hadjipavlou-Litina D, Pontiki E, Kralj M, Suman L, Zorc B. The novel ketoprofen amides–synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents. Chem Biol Drug Des 2010;75:641–652.
   PubMed Web of Science ®Google Scholar
• Boyd MR, Kenneth DP. Some practical considerations and applications of the National Cancer Intitute in vitro anticancer drug discovery screen. Drug Dev Res 1995;34:91–109.
   Web of Science ®Google Scholar
• Tzioumaki N, Manta S, Tsoukala E, Vande Voorde J, Liekens S, Komiotis D et al. Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: novel 5-fluorouracil analogs that target thymidylate synthase. Eur J Med Chem 2011;46:993–1005.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Melkoumian ZK, Lucktong A, Moniwa M, Davie JR, Strobl JS. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. J Biol Chem 2000;275:35256–35263.
   PubMed Web of Science ®Google Scholar
• Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch Toxicol 2002;76:287–298.
   PubMed Web of Science ®Google Scholar
• Werlinder V, Backlund M, Zhukov A, Ingelman-Sundberg M. Transcriptional and post-translational regulation of CYP1A1 by primaquine. J Pharmacol Exp Ther 2001;297:206–214.
   PubMedGoogle Scholar
• Backlund M, Weidolf L, Ingelman-Sundberg M. Structural and mechanistic aspects of transcriptional induction of cytochrome P450 1A1 by benzimidazole derivatives in rat hepatoma H4IIE cells. Eur J Biochem 1999;261:66–71.
   PubMedGoogle Scholar
• Loaiza-Pérez AI, Trapani V, Hose C, Singh SS, Trepel JB, Stevens MF et al. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole. Mol Pharmacol 2002;61:13–19.
   PubMed Web of Science ®Google Scholar
• Pontiki E, Hadjipavlou-Litina D. Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents. Bioorg Med Chem 2007;15:5819–5827.
   PubMed Web of Science ®Google Scholar
• C-QSAR Database: Biobyte Corp., 201 West 4th Street, Suite 204, Claremont, CA 91711.
   Google Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Rad Biol Med 1999;26:1231–37.
   PubMed Web of Science ®Google Scholar